Cytosorbents Corporation Stock Price and Value Analysis

Should you buy Cytosorbents Corporation stock? (NasdaqCM:CTSO). Let's see how it does in our automated value investing analysis system.

  • This company is not making money.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the CTSO Numbers

CTSO Price
(Cytosorbents Corporation stock price per share)
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Diagnostics & Research stocks
[?] Free Cash Flow Jitter 39%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 523,889 shares shorted. With 37,269,596 shares available for purchase and an average trading volume over the past 10 trading days of 104,910, it would take at least 4.994 days for all of the short holders to cover their shorts.

Is Cytosorbents Corporation Stock on Sale?

Based on our analysis, we believe that you should not buy Cytosorbents Corporation right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy CTSO Stock?

Does Cytosorbents Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.